Published in Arch Gen Psychiatry on October 01, 2005
Delivering Contingency Management in Outpatient Addiction Treatment (PRISE) | NCT04544124
Evolving the future: toward a science of intentional change. Behav Brain Sci (2014) 17.47
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. J Subst Abuse Treat (2007) 2.88
Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review. J Subst Abuse Treat (2008) 2.42
Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14
Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction (2007) 2.11
A vision of the next generation of behavioral therapies research in the addictions. Addiction (2007) 2.09
Evidence-based kernels: fundamental units of behavioral influence. Clin Child Fam Psychol Rev (2008) 2.01
Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry (2013) 1.92
Research participation and turnover intention: An exploratory analysis of substance abuse counselors. J Subst Abuse Treat (2007) 1.92
Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav (2006) 1.83
A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev (2008) 1.77
The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat (2010) 1.67
Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend (2006) 1.60
Reward circuitry function in autism spectrum disorders. Soc Cogn Affect Neurosci (2010) 1.54
Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med (2012) 1.48
Cost evaluation of evidence-based treatments. Addict Sci Clin Pract (2010) 1.42
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry (2014) 1.40
Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2010) 1.39
Strategies to encourage adoption in multisite clinical trials. J Subst Abuse Treat (2006) 1.38
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Counselor attitudes toward the use of motivational incentives in addiction treatment. Am J Addict (2010) 1.33
Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol (2008) 1.32
A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J Consult Clin Psychol (2012) 1.32
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction (2014) 1.25
Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics. J Appl Behav Anal (2008) 1.25
Prize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation. J Subst Abuse Treat (2010) 1.25
Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav (2011) 1.22
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? J Subst Abuse Treat (2010) 1.21
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol (2008) 1.20
Use of vouchers to reinforce abstinence and positive behaviors among clients in a drug court treatment program. J Subst Abuse Treat (2007) 1.19
Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. J Subst Abuse Treat (2010) 1.19
A deposit contract method to deliver abstinence reinforcement for cigarette smoking. J Appl Behav Anal (2008) 1.17
Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug Alcohol Depend (2007) 1.17
Study results from the Clinical Trials Network's first 10 years: where do they lead? J Subst Abuse Treat (2010) 1.16
Willingness to pay for drug rehabilitation: implications for cost recovery. J Health Econ (2007) 1.15
Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes. Drug Alcohol Depend (2006) 1.15
Clinic variation in the cost-effectiveness of contingency management. Am J Addict (2007) 1.14
Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend (2011) 1.14
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend (2008) 1.11
Retention of under-represented minorities in drug abuse treatment studies. Clin Trials (2009) 1.10
A randomized trial of contingency management delivered in the context of group counseling. J Consult Clin Psychol (2011) 1.07
Correlates of stimulant treatment outcome across treatment modalities. Am J Drug Alcohol Abuse (2009) 1.05
Compromised sensitivity to monetary reward in current cocaine users: an ERP study. Psychophysiology (2008) 1.05
Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry (2009) 1.05
Diffusion of contingency management and attitudes regarding its effectiveness and acceptability. Subst Abus (2010) 1.03
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03
Contingency management approaches for adolescent substance use disorders. Child Adolesc Psychiatr Clin N Am (2010) 1.03
Introduction to the special issue on the behavior analysis and treatment of drug addiction. J Appl Behav Anal (2008) 1.02
A randomized trial of contingency management delivered by community therapists. J Consult Clin Psychol (2012) 1.02
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care. Drug Alcohol Depend (2011) 1.02
Psychometric properties of the contingency management competence scale. Drug Alcohol Depend (2010) 1.00
Disseminating contingency management to increase attendance in two community substance abuse treatment centers: lessons learned. J Subst Abuse Treat (2010) 1.00
Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health (2010) 1.00
Gender differences in the rates and correlates of HIV risk behaviors among drug abusers. Subst Use Misuse (2010) 0.99
Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav (2013) 0.99
Modeling site effects in the design and analysis of multi-site trials. Am J Drug Alcohol Abuse (2011) 0.99
Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: meta-analytic findings across eight NIDA CTN trials. Am J Drug Alcohol Abuse (2011) 0.99
A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat (2010) 0.98
Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat (2010) 0.97
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend (2010) 0.97
Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. J Subst Abuse Treat (2010) 0.97
Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network. Am J Drug Alcohol Abuse (2011) 0.97
Contingency management treatments: controversies and challenges. Addiction (2010) 0.96
Nationwide dissemination of contingency management: the Veterans Administration initiative. Am J Addict (2014) 0.94
Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addict Behav (2007) 0.94
Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend (2011) 0.93
Contingency management promotes smoking reductions in residential substance abuse patients. J Appl Behav Anal (2008) 0.93
Latinos and Latinas in communal settings: a grounded theory of recovery. Int J Environ Res Public Health (2009) 0.92
Obesity and its relationship to addictions: is overeating a form of addictive behavior? Am J Addict (2009) 0.92
Facilitating the adoption of contingency management for the treatment of substance use disorders. Behav Anal Pract (2009) 0.92
Adoption of motivational interviewing and motivational enhancement therapy following clinical trials. J Psychoactive Drugs (2010) 0.91
Contingency management is efficacious for cocaine abusers with prior treatment attempts. Exp Clin Psychopharmacol (2008) 0.91
Voucher-based reinforcement for alcohol abstinence using the ethyl-glucuronide alcohol biomarker. J Appl Behav Anal (2012) 0.91
Characteristics of an outpatient treatment sample by primary substance of abuse. J Addict Med (2013) 0.90
Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults. Gen Hosp Psychiatry (2012) 0.90
Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs (2012) 0.89
Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders. Drug Alcohol Depend (2008) 0.89
Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study. Am J Addict (2008) 0.89
Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend (2011) 0.89
Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use. Drug Alcohol Depend (2011) 0.88
Is exposure to an effective contingency management intervention associated with more positive provider beliefs? J Subst Abuse Treat (2011) 0.88
The National Drug Abuse Treatment Clinical Trials Network: forging a partnership between research knowledge and community practice. Subst Abuse Rehabil (2011) 0.88
Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol (2010) 0.87
A developmental perspective on neuroeconomic mechanisms of contingency management. Psychol Addict Behav (2012) 0.87
Community-based addiction treatment staff attitudes about the usefulness of evidence-based addiction treatment and CBO organizational linkages to research institutions. Eval Program Plann (2011) 0.87
Training workshops positively impact beliefs about contingency management in a nationwide dissemination effort. J Subst Abuse Treat (2013) 0.87
Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management. J Appl Behav Anal (2008) 0.87
Contingency management treatment in substance abusers with and without legal problems. J Am Acad Psychiatry Law (2011) 0.87
Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037). Am J Drug Alcohol Abuse (2011) 0.85
Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen? Psychol Addict Behav (2010) 0.85
Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials. Am J Addict (2014) 0.85
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemp Clin Trials (2011) 0.85
Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug Alcohol Depend (2012) 0.85
Reinforcing Abstinence and Treatment Participation among Offenders in a Drug Diversion Program: Are Vouchers Effective? Crim Justice Behav (2009) 0.84
Engaging in job-related activities is associated with reductions in employment problems and improvements in quality of life in substance abusing patients. Psychol Addict Behav (2013) 0.83
A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness. Am J Psychiatry (2017) 0.83
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (2010) 23.55
The TIGR Rice Genome Annotation Resource: improvements and new features. Nucleic Acids Res (2006) 8.26
BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol (2002) 6.20
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Establishment of a diazepam preference in human volunteers following a differential-conditioning history of placebo versus diazepam choice. Exp Clin Psychopharmacol (2002) 4.85
Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry (2006) 4.64
Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol (2003) 4.18
Impact of HIV infection and HAART on serum lipids in men. JAMA (2003) 4.01
The institute for genomic research Osa1 rice genome annotation database. Plant Physiol (2005) 3.96
The UK10K project identifies rare variants in health and disease. Nature (2015) 3.89
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA (2008) 3.64
Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63
Acute arterial complications associated with total hip and knee arthroplasty. J Vasc Surg (2003) 3.51
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry (2007) 3.39
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res (2008) 3.20
Comparison and evaluation of methods for liver segmentation from CT datasets. IEEE Trans Med Imaging (2009) 3.03
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. Cell (2013) 2.94
A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction (2004) 2.93
Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proc Natl Acad Sci U S A (2011) 2.89
Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction (2007) 2.84
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med (2011) 2.67
Comparative analysis of state requirements for the training of substance abuse and mental health counselors. J Subst Abuse Treat (2006) 2.65
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging (2005) 2.54
Dopaminergic network differences in human impulsivity. Science (2010) 2.49
Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res (2010) 2.48
A physically transient form of silicon electronics. Science (2012) 2.47
Variation in gene expression patterns in human gastric cancers. Mol Biol Cell (2003) 2.39
Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control (2013) 2.38
Improving substance abuse treatment enrollment in community syringe exchangers. Addiction (2009) 2.32
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol (2009) 2.26
Evaluation of registration methods on thoracic CT: the EMPIRE10 challenge. IEEE Trans Med Imaging (2011) 2.24
Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst (2004) 2.23
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction (2013) 2.23
Nonracemic Betti base as a new chiral auxiliary: application to total syntheses of enantiopure (2S,6R)-dihydropinidine and (2S,6R)-isosolenopsins. J Org Chem (2005) 2.19
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol (2012) 2.12
Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction (2007) 2.11
Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. Stat Med (2004) 2.04
Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes (2013) 2.02
Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci (2010) 2.01
The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res (2009) 2.00
Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry (2006) 1.99
Teaching the teachers: national survey of faculty development in departments of medicine of U.S. teaching hospitals. J Gen Intern Med (2004) 1.97
Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr (2003) 1.95
Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health (2009) 1.93
A quality improvement intervention to facilitate the transition of older adults from three hospitals back to their homes. J Am Geriatr Soc (2009) 1.93
Trauma and substance cue reactivity in individuals with comorbid posttraumatic stress disorder and cocaine or alcohol dependence. Drug Alcohol Depend (2002) 1.92
Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry (2013) 1.92
Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry (2010) 1.91
Landscape dynamitic change in Mu Us Desert derived from Landsat TM data. J Environ Sci (China) (2003) 1.85
Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res (2006) 1.84
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp Clin Psychopharmacol (2002) 1.81
Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol (2006) 1.79
Status hearings in drug court: when more is less and less is more. Drug Alcohol Depend (2002) 1.78
Digital cameras with designs inspired by the arthropod eye. Nature (2013) 1.77
A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol (2004) 1.76
The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend (2007) 1.75
An empirical assessment of high-performing medical groups: results from a national study. Med Care Res Rev (2005) 1.75
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction (2002) 1.72
Altered default mode network connectivity in Alzheimer's disease--a resting functional MRI and Bayesian network study. Hum Brain Mapp (2011) 1.67
Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2004) 1.66
Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend (2007) 1.64
Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci (2012) 1.64
The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry (2003) 1.63
Prize-based contingency management does not increase gambling. Drug Alcohol Depend (2006) 1.63
Analysis of the Pythium ultimum transcriptome using Sanger and Pyrosequencing approaches. BMC Genomics (2008) 1.62
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis (2005) 1.59
Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation. Addiction (2013) 1.59
Identifying and aligning expectations in a mentoring relationship. Clin Transl Sci (2011) 1.58
Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend (2002) 1.56
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients. Drug Alcohol Depend (2005) 1.55
Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci (2008) 1.54
Perceptions of methadone maintained clients about barriers and facilitators to help-seeking behavior. Prog Community Health Partnersh (2007) 1.54
Pharmacotherapy for nicotine dependence. CA Cancer J Clin (2005) 1.54
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res (2006) 1.52
Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry (2005) 1.48
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology (2006) 1.47
Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res (2006) 1.47
"From the prison door right to the sidewalk, everything went downhill," a qualitative study of the health experiences of recently released inmates. Int J Law Psychiatry (2011) 1.45
A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. Biol Psychiatry (2012) 1.44
Shaping smoking cessation using percentile schedules. Drug Alcohol Depend (2004) 1.43
Faculty development in teaching skills: an intensive longitudinal model. Acad Med (2004) 1.43
The Alpha-defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum of Organisms. Clin Orthop Relat Res (2015) 1.43
The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res (2015) 1.42